Atea Pharmaceuticals Inc

NASDAQ:AVIR  
7.49
+0.24 (+3.31%)
Earnings Announcements

Atea Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Business Update

Published: 05/10/2022 10:42 GMT
Atea Pharmaceuticals Inc (AVIR) - Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Diluted Share Loss $0.51.
Q1 Earnings per Share View $-0.58 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.